• S&P 500: 1,351.95
  • Change: 0.00%
$10.00 0.00 (0%)
2/9/2012 4:00 PM

Human Genome Sciences (NASDAQ:HGSI)

CAPS Rating: 2 out of 5

The drug development company with three products advancing into late-stage clinical development: Albuferon(r) for chronic hepatitis C, LymphoStat-B(r) for systemic lupus erythematosus, and ABthraxtm for anthrax disease.

Current Price $10.00 Mkt Cap $1.91B
Open $0.00 P/E Ratio 0.00
Prev. Close $10.00 Div. (Yield) N/A (N/A)
Daily Range $9.60 - $10.27 Volume 500
52-Wk Range $6.51 - $30.15 Avg. Daily Vol. 0

News & Discussion Boards

Caps

How do you think HGSI will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

572 Outperform
140 Underperform
 

All-Star Players

140 Outperform
39 Underperform
 

Wall Street

21 Outperform
2 Underperform
 

Top HGSI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

jeffrycooks (71.85)
Submitted January 19, 2012

yes to rl

Add Comment | Reply | Report this Post

zzlangerhans (99.31)
Submitted January 23, 2012

I haven't done very well with Human Genome, missing an enormous potential gain on the success of Benlysta in clinical trials and then getting crushed when I thought the stock was oversold after approval. Lets see if I have better luck this time. In… More

Add Comment | Reply | Report this Post
HGSI VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about HGSI.

Recs

4
Member Avatar zzlangerhans (99.31) Submitted: 1/23/2012 11:53:53 AM : Underperform Start Price: $9.03 HGSI Score: -8.25

I haven't done very well with Human Genome, missing an enormous potential gain on the success of Benlysta in clinical trials and then getting crushed when I thought the stock was oversold after approval. Lets see if I have better luck this time. In 12/11 the stock bottomed at 6.64, which is about where I gave up on my green thumb, and has subsequently risen back to the 9 level.

The rise in share price seems to be predicated on optimistic language from management as well as takeover speculation. However, we already know that the net Benlysta revenue for Q4 will be about 26M, which isn't much of a jump from 7.8M and 18.8M in the preceding quarters. It certainly won't be enough to make much of a dent in the company's huge quarterly losses. A recent 500M debt financing indicates that the company may be digging in for a prolonged period of negative cash flow.

Report this Post Add Comment | Reply | Permalink

Recs

1
Member Avatar jeffrycooks (71.85) Submitted: 1/18/2012 8:17:47 PM : Outperform Start Price: $9.06 HGSI Score: +7.22

yes to rl

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar AKHENATENX (42.76) Submitted: 1/18/2012 7:00:07 PM : Outperform Start Price: $9.06 HGSI Score: +7.22

Sales pickup on lupus drugs

Report this Post Add Comment | Reply | Permalink
View All 99 Pitches »

Leaderboard

Find the members with the highest scoring picks in HGSI.

Score Leader

o1eary

o1eary (< 20) Score: +1,551.01

The Score Leader is the player with the highest score across all their picks in HGSI.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
Okcfirefighter < 20 4/27/2009 8/13/2010 Outperform 3Y $1.53 +553.59% +58.66% +494.94 0 Comment
gbux < 20 4/30/2009 Outperform 3W $1.67 +498.80% +54.12% +444.68 0 Comment
JonathanWolter 63.00 11/28/2008 Outperform 5Y $1.69 +491.72% +56.69% +435.03 0 Comment
MotleyGulibles 95.88 4/30/2009 Outperform 3Y $1.70 +488.24% +54.05% +434.18 0 Comment
ethicalfool 76.46 4/30/2009 Outperform NS $1.73 +478.20% +53.72% +424.48 0 Comment
appstatecap 91.80 12/30/2008 Outperform 5Y $1.77 +463.38% +56.83% +406.55 0 Comment
anoah60 < 20 5/15/2009 Outperform 3M $1.80 +455.56% +53.00% +402.56 0 Comment
NT2006 < 20 5/26/2009 Outperform 1Y $1.82 +450.96% +53.53% +397.43 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. StrykerFast < 20 5/14/2009 Outperform 5Y $1.85 +442.01% +52.17% +389.84 0 Comment
ofri 87.21 12/11/2008 Outperform NS $1.85 +440.54% +55.64% +384.90 0 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackPoisedTo 71.96 1/25/2012 Underperform 5Y $9.18 +8.93% +3.12% -5.81 0 Comment
TrackMaximGroup < 20 1/19/2012 Outperform NS $9.06 +10.38% +3.16% +7.22 0 Comment
TrackJimCramer 78.02 10/13/2011 Underperform 3W $11.01 -9.17% +10.43% +19.61 0 Comment
trackrbcdainraus 21.67 9/8/2011 Outperform NS $12.03 -16.87% +13.21% -30.08 0 Comment
TrackBreanMurray 69.41 8/23/2011 Outperform NS $14.10 -21.99% +9.62% -31.60 10/26/2011 @ $11.00 0 Comment
TrackZacks 70.75 5/23/2011 Underperform 3M $26.75 -13.27% -0.28% +12.99 7/16/2011 @ $23.20 1 Comment
TrackBarclaysCap 93.26 3/10/2011 Outperform NS $29.07 -65.60% +3.66% -69.26 0 Comment
TrackZacks 70.75 10/6/2010 Underperform 3M $28.91 -7.02% +2.12% +9.14 10/29/2010 @ $26.88 1 Comment
TrackRWBaird 90.46 7/22/2010 Outperform NS $25.13 -60.21% +24.94% -85.15 0 Comment
TrackCollinsStew 66.07 4/1/2010 Outperform NS $30.26 -66.95% +14.91% -81.86 0 Comment
TrackJesupLamont 55.82 4/1/2010 Outperform NS $30.26 -66.95% +14.91% -81.86 0 Comment
TrackRBCCapMkts 93.26 3/4/2010 Outperform NS $31.40 -68.15% +20.37% -88.53 0 Comment
TrackJimCramer 78.02 11/4/2009 Outperform 3W $26.48 -58.42% +14.86% -73.28 10/13/2011 @ $11.01 0 Comment
TrackJPMorgan < 20 10/30/2009 Outperform NS $19.26 +43.77% +12.95% +30.82 4/30/2010 @ $27.69 0 Comment
TrackPiperJaff 88.99 9/15/2009 Outperform NS $19.00 -47.37% +30.93% -78.29 0 Comment
TrackUBS 93.25 9/5/2009 Outperform NS $18.86 -46.98% +34.85% -81.83 0 Comment
trackthinkequity 92.04 7/21/2009 Outperform NS $12.38 -19.22% +41.86% -61.08 0 Comment
TrackCitigroup 93.11 7/20/2009 Outperform NS $10.89 -8.17% +43.65% -51.82 0 Comment
TrackLazardCapit 78.98 6/12/2009 Underperform NS $2.89 +276.82% +0.33% -276.49 7/20/2009 @ $10.89 0 Comment
trackthinkequity 92.04 6/5/2009 Underperform NS $3.04 +307.24% -0.15% -307.38 7/21/2009 @ $12.38 0 Comment
trackthinkequity 92.04 2/27/2009 Outperform NS $2.09 +45.45% +28.83% +16.62 6/5/2009 @ $3.04 0 Comment
trackthinkequity 92.04 1/27/2009 Underperform NS $2.11 -0.95% -11.92% -10.97 2/27/2009 @ $2.09 0 Comment
TrackStanfordRes 85.10 12/10/2008 Outperform NS $1.94 +415.46% +53.95% +361.52 0 Comment
TrackDeutscheSec 92.40 1/24/2008 Outperform NS $6.20 +61.20% +4.17% +57.03 0 Comment
TrackUBS 93.25 1/24/2008 Outperform NS $5.87 -55.37% -34.46% -20.91 7/13/2009 @ $2.62 0 Comment
TrackBearStearns 94.70 1/24/2008 Outperform NS $6.10 +63.93% +4.90% +59.04 0 Comment
TrackRWBaird 90.46 1/24/2008 Outperform NS $6.10 -89.38% -49.21% -40.16 3/9/2009 @ $0.65 0 Comment
TrackJMP 86.37 1/23/2008 Outperform NS $5.64 +77.30% +6.13% +71.18 0 Comment
TrackLeerinkSwan 87.91 1/2/2008 Outperform NS $10.79 -7.32% -3.52% -3.80 0 Comment
TrackSchneider < 20 9/30/2007 Outperform NS $10.29 -2.82% -7.05% +4.23 2 Comments
TrackEdwardOwens 98.63 9/30/2007 Outperform NS $10.29 -2.82% -7.05% +4.23 2 Comments
TrackEveillard 96.01 9/30/2007 Outperform NS $10.29 +1.46% -4.17% +5.63 12/31/2007 @ $10.44 1 Comment
TrackBernstein 86.98 9/18/2007 Outperform NS $9.75 +2.56% -4.54% +7.11 0 Comment
TrackJimCramer 78.02 7/25/2007 Underperform 3W $8.10 +226.91% -30.80% -257.71 11/5/2009 @ $26.48 0 Comment
TrackStifel 96.90 1/31/2007 Outperform NS $11.81 -15.33% +0.73% -16.06 0 Comment
TrackAGEdwards < 20 1/4/2007 Outperform NS $12.48 -15.14% +9.10% -24.24 6/1/2007 @ $10.59 0 Comment
TrackSusquehanna 78.03 11/21/2006 Outperform NS $12.91 -80.48% -35.82% -44.66 11/11/2008 @ $2.52 0 Comment
TrackLazardCapit 78.98 10/12/2006 Underperform NS $12.80 -36.41% +10.29% +46.69 7/26/2007 @ $8.14 0 Comment
TrackTWeisel 91.88 10/11/2006 Outperform NS $12.88 -22.36% +6.55% -28.91 0 Comment

Featured Broker Partners